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Abstract: It has become increasingly important to qualitatively and quantitatively assess the volatile
metabolites in a range of bodily fluids for use in monitoring health. There has been relatively
little work on the quantitative analysis of compounds, particularly with respect to the effects of
ethnicity or geographic location. A novel method for the quantification of compounds in stool
using 13C labelled compounds as internal standards is presented. Using thermal desorption gas
chromatography mass spectrometry, stool samples from 38 healthy volunteers were analysed. The 13C
labelled compounds, acetone, ethyl butanoate, ethanoic acid, butanoic acid, 3-methylbutanoic acid,
and indole, were added as internal standards. This process mimics the solubility characteristics
of the compounds and thus the method was able to quantify the compounds within the solid
stool. In total, 15 compounds were quantified: Dimethyl sulphide (26–25,626 ng/g), acetone
(442–3006 ng/g), ethyl butanoate (39–2468 ng/g), ethyl 2-methylbutanoate (0.3–180 ng/g), dimethyl
disulphide (35–1303 ng/g), 1-octen-3-one (12 ng/g), dimethyl trisulphide (10–410 ng/g), 1-octen-3-ol
(0.4–58 ng/g), ethanoic acid (672–12,963 ng/g), butanoic acid (2493–11,553 ng/g), 3-methylbutanoic
acid (64–8262 ng/g), pentanoic acid (88–21,886 ng/g), indole (290–5477 ng/g), and 3-methyl indole
(37–3483 ng/g). Moreover, by altering the pH of the stool to pH 13 in conjunction with the addition
of 13C trimethylamine, the method was successful in detecting and quantifying trimethylamine for
the first time in stool samples (range 40–5312 ng/g). Statistical analysis revealed that samples from
U.K. origin had five significantly different compounds (ethyl butanoate, 1-octen-3-ol, ethanoic acid,
butanoic acid, pentanoic acid, and indole) from those of South American origin. However, there were
no significant differences between vegetarian and omnivore samples. These findings are supported by
pre-existing literature evidence. Moreover, we have tentatively identified 12 compounds previously
not reported as having been found in stool.
Keywords: gas-chromatography mass-spectrometry; volatile compounds; quantification; carbon
isotopes; stool
1. Introduction
Numerous studies have been conducted which present volatile compounds (VCs) as potential
biomarkers for gastrointestinal (GI) disease states [1–4]. For instance, Garner et al. showed VCs
were significantly different in infected patients with C. difficile, and C. jejuni compared to healthy
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participants [2]. Similarly, a pilot study suggested potential VC biomarkers of cholera [1]. Other work
has suggested the VCs emitted from stool can have potential in the diagnosis of irritable bowel
syndrome (IBS) and inflammatory bowel disease (IBD) [3–5]. Currently, GI diseases are commonly
diagnosed invasively, via blood tests, endoscopy, and biopsy, while VC analysis of stools is non-invasive
and is potentially more economical.
However, if VCs are to have real clinical utility, it is crucial that the healthy state volatilome is
better understood. The gut is known to contain a vast and dynamic population of bacteria, with an
estimated 100 trillion bacteria comprised of ca. 1000 species [6]. Currently, some 381 compounds have
been identified from human stool, and this number may be unrepresentative considering over double
this number of compounds have been identified in breath [7]. This discrepancy may simply be due to
fewer studies attempting to identify compounds from stool rather than breath due to the increased
complexity of sample gathering and difficulty in obtaining healthy stool samples. Determining the
healthy gut volatilome is problematic as dietary alterations can both alter the composition of the
microbiota and the metabolites produced [8]. For instance, Geypens et al. [9] investigated the effect
of a high protein diet on VCs in stools, measuring the volatiles before and after a whey-protein
supplemented diet in healthy volunteers. The study identified 120 VCs, 10 of which appeared or
increased after the protein-rich diet, particularly dimethyl trisulphide and short-chain fatty acids
(SCFAs). Silvester et al. showed that high protein meals can also contribute to an increase in the
production of N-nitroso compounds and ammonia by intestinal flora [9].
Currently, the quantification of volatiles from biological samples are mostly restricted to real-time
methods, such as selected ion flow tube mass spectrometry (SIFT-MS) [10]. However, the use of GC-MS
in the quantification of volatile compounds has previously been reported using solid phase micro
extraction (SPME) to sample latrine models [11]; 10 VOCs were quantified, with butanoic acid being
found in the highest concentration with a range of 46.2–13,578 µg/g, whereas dimethyl sulphide was
measured in the lowest concentration range of 0.02–2.1 µg/g [11].
Walton et al. quantitatively analysed VCs in the faecal headspace before and after treatment from
patients with Crohn’s disease (CD), ulcerative colitis (UC), and irritable bowel syndrome (IBS), and
healthy controls. Following treatment, only propanoic acid ethyl ester remained significantly different
across the groups [12]. Similarly, Baranska et al. used breath samples to differentiate IBS patients from
healthy controls using GC time-of-flight mass spectrometry. This study suggests a set of 16 biomarkers
that could be used to not only predict IBS, but also monitor its progression [13].
Wang et al. analysed stool samples of autistic spectrum disorder (ASD) children and healthy,
age-matched controls for short chain fatty acids, phenols, and ammonia. Those with ASD had higher
concentrations of acids than the controls and higher faecal ammonia [14].
De Preter et al. used purge and trap GC-MS analysis to quantify VCs in dried stool samples
using calibration curves with diethyl sulphide, 2,6-dimethylphenol, and 2-ethylbutyric acid used as
internal standards. A total of 135 different VCs were reported with 22 compounds common to all
volunteers. Butanoic acid was found in the highest concentration with a range of 5–500 mg/L and
dimethyl sulphide was found in the lowest concentration with a range of 5–1000 µg/L [15].
GC-MS analysis of VOCs from the human body has typically provided qualitative data and
limited work exists on the quantification of metabolites in human stool. However, a method has
been developed based on using internal 13C labelled standards to calculate concentrations of key
compounds in the solid stool sample and the headspace. This study used stool from participants
of different nationalities and varying diets (vegetarian/omnivore) to assess the difference in VC
composition. Knowing what constitutes a “healthy” profile across a range of geographic locations
allows a better understanding of the deviations from this profile, which may be indicative of disease.
No work has appeared to be published on VC analysis with pH alteration of stool. Altering the pH of
stool to alkaline conditions was explored to allow quantification of some amine compounds.
This study qualitatively identified compounds associated with stool samples from healthy
volunteers and thus adds knowledge to the established human volatilome.
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2. Results
2.1. Qualitative Data from Unmodified Stools
Tables S1–S12 show the raw qualitative data from all 38 samples; in total, 174 distinct
chromatographic peaks were recorded across these samples; the supplementary tables show these
compounds separated into chemical class. The mean number of peaks above the noise threshold was
57 per sample with a range of 36–72. Of the total number of chromatographic peaks, 32 could not
be identified by the NIST library and 30 were identified as unspecified terpenes. Table S13 shows
retention indices (RI) values calculated from the experimental data and compared where possible
to literature values. All RIs for the unidentified and terpene compounds have also been calculated.
Table S13 also highlights which compounds have been validated using standards.
2.2. Quantitative Data from Unaltered Stools
Table 1 shows the mean and standard deviation for each compound in nanograms per gram of
stool for all samples. The raw data for each individual sample can be found in Table S14. Table 1
also shows the mean concentration (ng/g) and standard deviation for each compound separated by
samples of UK and South American origin, as these were the two largest groups.
Table 1. The mean concentration (ng/g) and standard deviation for compounds quantified from the
stool of healthy participants using GC-MS. The mean concentration (ng/g) and S.D. of each compound
from the UK and South American participants has also been compared.
Origin Number ofSamples
Number of
Times Detected Mean (ng/g)
Std. Deviation
(ng/g)
Range
(ng/g)
Dimethyl sulphide
CAS 75-18-3
Total 38 37 3058 4531 25–25,626
UK 16 16 2474 2913 26–8637
South
America 11 10 2890 2780 621–8079
Acetone
CAS 67-64-1
Total 38 38 1481 626 442–3005
UK 16 16 1335 614 442–2521
South
America 11 11 1652 487 819–2377
Ethyl butanoate
CAS 105-54-4
Total 38 21 352 659 39–2468
UK 16 14 424 714 39–2468
South
America 11 3 121 263 118–828
Ethyl 2-methylbutanoate
CAS 7452-79-1
Total 38 12 8 29 0.34–180
UK 16 10 16 44 0.3–180
South
America 11 2 4 12.8 9–42
Dimethyl disulphide
CAS 624-92-0
Total 38 38 479 406 35–1302
UK 16 16 301 275 48–864
South
America 11 11 583 445 36–1313
1-Octen-3-one
CAS 4312-99-6
Total 38 1 0.31 2 12
UK 16 1 0.74 3 12
South
America 11 0 0.00 0 Not detected
Dimethyl trisulphide
CAS 3658-80-8
Total 38 38 132 116 10–409
UK 16 16 81 69 10–253
South
America 11 11 156 119 13–364
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Table 1. Cont.
Origin Number ofSamples
Number of
Times Detected Mean (ng/g)
Std. Deviation
(ng/g)
Range
(ng/g)
1-Octen-3-ol
CAS 3391-86-4
Total 38 13 4 13 0.4–58
UK 16 10 11 18 1–58
South
America 11 3 0.35 0.72 0.4–2
Ethanoic acid
CAS 64-19-7
Total 38 38 8756 2246 672–12,963
UK 16 16 7400 2607 672–11,343
South
America 11 11 9583 1411 7968–12,963
Butanoic acid
CAS 107-92-6
Total 38 38 7556 2310 2493–11,553
UK 16 16 5783 2160 2493–8376
South
America 11 11 8740 800 7043–9953
3-Methylbutanoic acid
CAS 503-74-2
Total 38 36 2726 2210 63–8262
UK 16 16 1363 1029 64–3602
South
America 11 10 3391 2555 220–6885
Pentanoic acid
CAS 109-52-4
Total 38 37 4443 4374 88–21,886
UK 16 16 2078 1720 88–5970
South
America 11 11 7494 5879 946–21,886
Indole
CAS 120-72-9
Total 38 38 3717 1119 290–5477
UK 16 16 3002 797 1508–4309
South
America 11 11 4174 649 3286–5477
3-Methyl-1H-indole
CAS 83-34-1
Total 38 38 1323 776 37–3483
UK 16 16 1340 799 425–3054
South
America 11 11 1703 777 636–3483
Trimethylamine
CAS 75-50-3 Total 15 15 241 157 40–920.5
2.3. UK Samples versus South America Samples
Mann Whitney U tests revealed six compounds to be significantly different between UK and
South American samples, and these are shown in Table 2.
Table 2. Statistical analyses showing significant differences (95% significance level) for six compounds
using Mann Whitney U tests to determine differences in the quantities of compounds measured in
stool from UK and South American participants.
Compound Sig.
Ethyl butanoate 0.023
1-Octen-3-ol 0.034
Ethanoic acid 0.011
Butanoic acid 0.000
Pentanoic acid 0.001
Indole 0.000
Discriminant analysis using stepwise statistics (Wilks’ Lambda) calculated butanoic acid and
ethyl butanoate as being the two significant grouping variables.
Figure 1 shows a plot of the discriminant scores versus country of origin. There is a clear difference
between the groups, with the South American sample set having a smaller range of scores versus the
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UK samples. This demonstrates that, with the exception of the outliers, the two means are very well
separated. Figure 2 shows the resultant receiver operator curve (ROC) from the calculated discriminant
scores; the area under the curve was 0.937 with a standard error of 0.044. This shows close to perfect
separation of the U.K. and South American samples based on differences in the concentration of
butanoic acid and ethyl butanoate. These two compounds alone can predict group membership.
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Figure 1. Discriminant scores’ box plots showing the differentiation between UK and South American
stool samples (Wilks’ Lambda analysis showed butanoic acid and ethyl butanoate to be the significant
grouping variables).
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2.4. Omnivore versus Vegetarian
The same series of statistical tests were carried out comparing vegetarians and omnivores; Table 3
shows the mean concentration (ng/g) and standard deviation for each compound. However, in this
instance, there was no statistically significant differences in those compounds analysed. Discriminant
analysis using stepwise statistics (Wilks’ Lambda) calculated that the most significantly different
compound was dimethyl trisulphide with a p = 0.055. The discriminant scores for this compound
measured in the omnivore and vegetarian groups are plotted in Figure 3. While the range of
discriminant scores is wider for omnivore participants, the two groups completely overlap, illustrating
the lack of any significant difference between the two groups.
Table 3. The mean concentration (ng/g) and measured concentration range (ng/g) for each compound
in the omnivore and vegetarian diet groups.
Diet Number ofSamples
Number of
Times Detected Mean (ng/g)
Std. Deviation
(ng/g)
Range
(ng/g)
Dimethyl sulphide
75-18-3
Vegetarian 14 14 4182 6818 91–25,626
Omnivore 24 23 2403 2354 26–8089
Acetone
CAS 67-64-1
Vegetarian 14 14 1285 522 442–2287
Omnivore 24 24 1595 663 453–3006
Ethyl butanoate
CAS 105-54-4
Vegetarian 14 7 243 511 39–1659
Omnivore 24 14 415 735 40–2468
Ethyl 2-methylbutanoate
CAS 7452-79-1
Vegetarian 14 4 1 4 0.3–13
Omnivore 24 8 12 37 8–180
Dimethyl disulphide
CAS 624-92-0
Vegetarian 14 14 355 335 37–1058
Omnivore 24 24 553 432 35–1303
1-Octen-3-one
CAS 4312-99-6
Vegetarian 14 1 0.85 0 12
Omnivore 24 0 0.00 0 Not detected
Dimethyl trisulphide
CAS 3658-80-8
Vegetarian 14 14 85 69 11–199
Omnivore 24 24 160 130 10–410
1-Octen-3-ol
CAS 3391-86-4
Vegetarian 14 6 8 14 2–38
Omnivore 24 7 3 12 0.4–58
Ethanoic acid
CAS 64-19-7
Vegetarian 14 14 8799 2155 4298–12,233
Omnivore 24 24 8731 2343 672–12,963
Butanoic acid
CAS 107-92-6
Vegetarian 14 14 7452 2938 2493–11,553
Omnivore 24 24 7618 1922 2681–9633
3-Methylbutanoic acid
CAS 503-74-2
Vegetarian 14 14 2319 1974 64–5821
Omnivore 24 22 2965 2344 220–8262
Pentanoic acid
CAS 109-52-4
Vegetarian 14 14 3123 2841 88–10,216
Omnivore 24 23 5213 4953 730–21,886
Indole
CAS 120-72-9
Vegetarian 14 14 3340 1505 290–5477
Omnivore 24 24 3938 772 2342–5070
3-Methyl-1H-indole
CAS 83-34-1
Vegetarian 14 14 1160 633 37–2267
Omnivore 24 24 1419 846 404–3483
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Figure 3. Discriminant scores’ box plots showing a lack of differentiation of stool samples from
vegetarian and omnivore volunteers.
2.4.1. Qualitative Data f om Alkaline (pH 13) Stools
A total of 15 stool samples were analysed after the addition of sodium hydroxide to alter the
pH to 13. A total of 133 chromatographic peaks were recorded across the 15 samples with a mean of
43 peaks per chromatogram; with the lowest number of peaks being 29 and the high st 53. Of the total
number of peaks, 16 were unidentified and 43 were catego ised as terpenes. Tables S15–S25 in the
Suppl mentary Material shows the qualitative data s parat d by chemical class.
2.4.2. Quantitative Data from Alkaline (pH 13) Stools
Figure S1 shows the comparison between chromatograms of unaltered stool (Figure S1a) and
the same sample with 5 mL of 0.1 M sodium hydroxide added (Figure S1b). As expected, the
region containing the majority of the short ain fatty cids (reten ion time 7–18 min) has both
le s chromatograp ic peaks and smaller peak a eas when the sodium hydroxide is ad ed. However,
Figures S1 and S2 clearly show that whe sodium hydroxide is added to make the stool alka i, the
tri ethylamine can be detected. In the unmodified stool (Figure S1a) the e is no 58 m/z peak at the 1.94
min retention time, whic is indicative of trimethylamine. The peak wi h a ret ntion f 1.91 in Figure
S1a does not have any cl ar matches in the NIST library. This peak is no longer visible when only the
58 /z for trimethyla ine is displayed as sh wn in e section of the chromatogram displayed in
Figure S2a. Whereas the identical section of the chromatogram for the pH altered stool g ves a peak at
the earlier retention t with a library match for trimethylamine (Figure S2b).
3. Discussion
It is considered that some diseases could be linked to the microbiome [16]. There is a lack of
knowledge of gut chemistry, due in part to the shear complexity of the stool mixture. Recently,
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hundreds of new compounds have been identified in the gut mainly due to the VC analyses in
headspace studies, and much of this work is of a qualitative nature [4,17]. We have developed a
method for quantifying key compounds from stool samples, which minimizes chemical alterations
to the stool using 13C isotope labelled internal standards. It quantifies headspace concentrations and
accounts for dissolved stool concentrations by comparing the distribution and relative recovery of
isotope labelled compounds from the headspace above stool.
We have also devised a method to quantify trimethylamine in stool by using isotope 13C labelled
trimethylamine in conjunction with elevating the pH to 13. Although addition of base to stool samples
is not common, Wang et al. also added sodium hydroxide to stool prior to the sample being centrifuged
and filtered to measure lactic acid and SCFAs with high-performance liquid chromatography [18].
However, in the Wang et al. study, no healthy participants were used, and all the participants were
premature infants. This study also differs from our study as only 1 mL of 10 mmol/L sodium hydroxide
was added along with 5 mmol/L of crotonic acid, with no mention as to the effect these additions had
on the pH.
Walton et al. used TD-GC-MS, a similar method to that reported here, to analyse the headspace
of stool samples. They found levels of acetone that were 142 ng/L whereas butanoic acid was
33 ng/L, 3-methylbutanoic acid was 7 ng/L, and Indole was 9 ng/L. Measuring the headspace
concentration underestimates the level of free acid and other compounds, such as indole, in the
stool, due to the relatively low concentrations portioning into the headspace. To determine the
differences in quantification of the headspace concentrations versus the in-stool concentrations,
headspace quantification was done on a subset of samples (16 UK samples). Although the levels
of acetone, dimethyl sulphide, and other lower molecular weight, less water soluble, and lower
boiling point compounds were equivalent to the values measured during the quantitation studies
for the same samples (Table 1 and Table S14, UK participants), much lower amounts of acids and
indole were determined if just pure headspace concentrations were measured (see Supplementary
Table S26). Thus, the method we devised considered the headspace concentration vs. dissolved
concentration, by dissolving a known 13C isotope with similar chemical properties into the stool and
measuring headspace concentrations, but correcting for lower than expected recovery and applying
this same correction factor to the levels detected (peak areas) of the non-isotope labelled naturally
occurring compounds.
As mentioned, fatty acids and indole concentrations in stool are disproportionately
underestimated if just the headspace concentration is considered. The devised method does rely
on distributing the 13C labelled compound throughout the stool sample. To ensure the best possible
distribution, method development identified the use of a ball bearing to homogenise the thawing stool
sample plus isotope labelled standard. We measured recoveries of isotope labelled compounds and
non-labelled standards from an empty vial. This showed 100% recovery for acetone, but as expected,
less than 100% for indole and the fatty acids. The recovery for labelled standards and non-labelled
standards was almost identical as expected due to the similar chemical properties. The relative
recovery of compounds is not used in the final calculation as lower amounts of certain isotope labelled
compounds (acids and indole) are expected to be recovered—but this is balanced by the correction
that would have to be applied to account for the lower amounts of naturally occurring compounds
from the stool that would be measured (recovered) vs. the actual concentration in stool.
Extensive method development was undertaken using standard mixtures containing
18 compounds previously identified in stool to optimise the chromatography method and automated
thermal desorption (ATD) tube loading. Prior to this, a number of different solvents had been used
for the standard mixture and methanol was selected due to its compatibility with a wide range of
compounds, ease of removal from ATD tubes when loading calibration standards, and minimal solvent
peak, which did not interfere with the compounds of interest in unmodified stool.
The method relies on correcting recovered values based on the 13C standard recovery. This gives
a more realistic quantitation for the amount of certain compounds in stool. However, if the naturally
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occurring compounds of interest are below the limit of detection for the headspace analysis method,
then there is no way to apply the correction to ascertain the actual concentration of the compound in
stool. Therefore, a solvent extraction method, which does not rely on working close to the limit
of detection, may have enabled quantitation of the full range of samples. Prior to developing
the headspace-based method reported here, a solvent extraction method had been developed for
quantifying selected compounds in stool. However, it proved difficult to obtain a reliable solvent
extraction method that enabled simultaneous quantitation of the compounds of interest, which span a
broad range of chemical classes.
Wang et al. utilized a vacuum distillation process to isolate the short chain fatty acids (SCFAs) in
stool [14]. These studies identified higher levels of SCFA than the method reported here, with levels in
the high µg/g range compared to this study where values were in the low µg/g range. Wang et al.
obtained median values of 3705 µg/g for ethanoic acid, 1756 µg/g for butanoic acid, and 285 µg/g for
3-methylbutanoic acid. These values are higher than those reported here due to the methodology used,
whereby both the free acid and anionic forms would be extracted and analysed.
De Preter et al. freeze dried their stool samples before they were salted with sodium sulphate and
acidified with sulphuric acid [15]. Acidification of stool samples is a reasonably common technique as
detailed in a comprehensive review of SCFA analysis via GC and other methods [19]. Their reported
values for the SCFAS measured (ethanoic acid, butanoic acid, and 3-methylbutanoic acid) were in the
high µg/g range in agreement with the studies of Wang et al. detailed above [14]. Interestingly, de
Preter also quantified dimethyl sulphide and found levels of 0–402 ng/g whereas this study identified
DMS at a mean concentration of 3058 ng/g with a range of 26–25,626 ng/g. So, there is fairly good
agreement between the two different analysis methods for quantifying volatile sulphur compounds,
and this is because the alteration of the chemistry does not affect the quantification of sulphides in
the same way as SCFAs. De Preter also quantified indole and found levels ranging from 24 µg/g to
44 µg/g whereas this study found mean values of 3 µg/g. Therefore, there is fairly good agreement
that can be explained by the different effects altering the stool chemistry has on quantifying indole vs.
quantifying SCFAs.
As mentioned, by the action of acidifying stool, both the free acid and the previously anionic
form is measured. However, in the gut, the acid exists as free acid, but also more so in the anionic
form [20] (with the counter cation being H+, metal cations, and, to a lesser extent, ammonium ions).
Our contention is that quantification of the free SCFA concentration in addition to the total SCFA
concentration is important to know in a study of the gut chemistry. The amount of free acid will dictate
the amount of acid detectable in the headspace and thus the amount available for potential diagnostic
purposes [21].
Preliminary work on the basification of stool was reported. The unmodified stools yielded a
mean of 174 peaks across 38 samples with a mean of 57 per sample (range 36–73). The addition of
the sodium hydroxide reduced both values significantly to 133 and 43 (range 29–53), respectively.
Moreover, as demonstrated in Figure S1a,b, after the first 10–12 min, the frequency and size of the
chromatographic peaks notably reduces. By making the stool alkali, we have shown that it is possible
to not only detect, but also quantify, trimethylamine, which is likely to be a result of the conversion of
protonated trimethylamine to trimethylamine in the high pH conditions. Figure S2b shows a clear
peak with an RT of 1.94 after the sodium hydroxide is added, which is identified by the NIST library
with a match and reverse-match at 999 and 992, respectively. Figure S2a shows the same sample with
unmodified stool in which the 1.94-min peak is barely visible. Lin et al. found that in their latrine
models, the amine smell became more prominent as the pH increased to 9 [11]. They also found that
trimethylamine could not be detected from their field samples, and this could be due to the presence
of acids in the sample protonating the amine compounds [9], resulting in a lack of free trimethylamine
within the samples. Simenhoff et al. suggested that secondary and tertiary amines were in high levels
on the breath of patients with end stage renal disease [22]; a finding that was also supported by Davis,
Spanel, and Smith [23]. Moreover, ammonia has been associated with hepatic encephalopathy [24].
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Thus, improving amine detection techniques could have clinical utility in the future. While we were
unable to quantify any other amine compounds in this instance, we are confident that with further
method development we should be able to quantify more amine compounds. We were able to identify
methylamine in one of the stools modified to pH13, and this peak eluted as a shoulder to the methanol
solvent peak; this is suggestive that methylamine may be in other samples, but co-elutes with the
solvent peak. Thus, developing the method further to reduce or eliminate this solvent peak, for
instance, by increasing the tube collection purge time to drive off more methanol, may reveal more
amine compounds. Table 4 shows the differences in the number of compounds detected for each
chemical class between the unaltered and alkaline stool samples. There were fewer compounds
detected across all the chemical classes, with the exception of nitrogen containing compounds, in the
alkaline stool; not surprisingly, the largest percentage decrease in the number of compounds came
from the acids with a 70% decrease. The least change came from the esters, which only decreased by
17% following pH alteration. As expected the only class of compounds that showed an increase in
numbers were the nitrogen containing compounds. 1,6-Octadien-3-ol-3,7-dimethyl-2-aminobenzoate
was detected in the unmodified stool, but was not detected in the alkaline stool. Trimethylamine,
dimethylamine, and acetonitrile (dimethylamino) were detected in the alkaline stool, but not in the
unmodified stool. Acetonitrile, indole, and 3-methyl indole were seen in both unmodified and pH
modified stool.
Table 4. Comparison of compounds found across different classes of chemicals in unmodified stool
and the stool modified to pH 13.
Chemical Family Unmodified pH Modified Percentage Decrease(Unmodified to pH13 Modified)
Aldehydes 6 3 50%
Esters and thioesters 36 30 17%
Ketones 12 7 42%
Alcohols 20 11 45%
Acids 10 3 70%
Nitrogen containing 4 6 50%
Sulphides 8 3 63%
Aromatic compounds 6 5 29%
Miscellaneous 2 0 100%
Terpenes 30 22 40%
Unidentified 32 16 50%
The origins of a majority of the esters could arise from reactions between the alcohols and acids
reported here. A homologous series of alcohols from ethanol to octanol was found, and from ethanoic
acid to heptanoic acid, in agreement with previous work [25], and their reaction would produce many
straight chain esters. Branched chain esters can similarly be explained by a reaction of, for example,
3-methylbutanoic acid with alcohols. Interestingly, a large number of methyl esters (nine in total) were
found although no free methanol was observed. It may be that that the body, or bacterial enzymes,
particularly “trap” methanol as esters, reduce the methanol’s toxic effects on cells.
The statistical tests on the gathered data showed that five compounds were in significantly
different quantities in stool gathered from UK and South American participants; significantly, these
participants were temporarily living in the UK with little exposure to a UK diet due to the short
duration of their time in the UK. Moreover, using one cross validation, we were able build an example
model using butanoic acid and ethyl butanoate to differentiate UK and South American samples; albeit,
this was based on a small dataset. However, there was very little overlap between the two groups.
In many clinical studies, there is little attention paid to the ‘healthy’ participants; however, developing
a comprehensive understanding of how healthy samples can differ from population to population
could be significant in the development of VC based diagnostics. For example, a stool volatile based
diagnostic test that has high accuracy in the UK may not exhibit the same accuracy in a South American
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population. The results presented here do seem to suggest that further work is required to assess the
difference in volatile profiles of healthy participants of different geographical origins.
A 2010 study compared the microbiota of children from Burkina Faso with children from
the European Union (EU) [26]. This team suggested that there was a significant difference in the
composition of gut microbiota between the two groups; they proposed the increased sugar, animal
fats, and general calorie dense foods as the reason for this difference [26]. A difference in microbiota
composition will inevitably lead to differences in the faecal volatilome. Similarly, a research team from
China assessed the gut microbiota of 314 healthy participants of different geographical origins within
China. This group was also able to determine differences in the composition of gut microbiota from
these geographical origin groups; interestingly, this study was unable to determine any difference as
a result of lifestyle. However, importantly, the team state they did not process the necessary dietary
information to make any inferences on the role diet plays in the formation of microbiota [27]. A 2006
study examined the gut microbiota of four different European countries; in this instance, very few
differences were noted as a result of country of origin, however, this study suggested that other
factors, such as age and gender, conferred significant differences [28]. Taken together, there is sufficient
evidence to say that there are a number of variables that can influence the gut microbiota and, in turn,
the associated volatilome.
Comparing the quantities of the compounds in omnivore samples versus vegetarian samples
revealed no significant differences between the two groups, as evidenced by the discriminant scores
plot shown in Figure 3. There have been numerous publications that suggest why this might be the
case, for instance, Kabeerdoss et al. compared the microbiota of female southern Indian omnivores and
vegetarians. This groups found that, with the exception of Clostridium cluster XIVa and some butanoate
producing bacteria, which were more prevalent in omnivores, the groups were very similar [29].
While our results showed no significant difference due to the large standard deviations, the butanoic
acid, ethyl butanoate, and ethyl 2-methylbutanoate were all higher in the omnivore group versus
the vegetarian group. Van Faassen et al. demonstrated that while stool mass and frequency was
higher in vegetarians versus omnivores, the pH of the stool was not significantly different; this was
attributed to both vegetarians and omnivores having similar calcium intake [30]. In a recent 2015 study,
Ferrocino et al. assessed the gut microbiota of 153 healthy participants from five different regions of
Italy. This group also found that significant differences in gut microbiota could be attributed to region
of origin rather than dietary habits (vegetarian/omnivore) [31].
A 2014 review of the healthy human volatilome found 381 distinct compounds from human
stool [25]. Overall, we were able to identify 106 distinct compounds; moreover, we have tentatively
identified additional compounds that have not previously been reported in the literature from stool
samples of healthy participants (see Table 5). However, 3-Methyl-2-butanone has previously been
reported in the urine samples of healthy individuals [31]. The compound, 2,4-dithiapentane, has
been associated with white truffles [32] and truffle oil [33], and is likely to be directly derived from
diet. Cyclohexanol, 5-methyl-2-(1-methylethyl)-(1a,2b,5a) is a none verified isomer of menthol [34],
and 4-isopropyl benzaldehyde is better known as a cuminaldehyde and both of these compounds
are found in food [35]. Table 6 shows a further three compounds that were identified in the alkali
treated stool samples that have not previously been reported in the current literature concerning
volatile compounds emanating from stool of healthy individuals, but acetonitrile (dimethylamino) was
identified in the headspace above stool of patients with C. difficile [2]. It is important to understand
more about the volatilome if volatile compounds are going to prove useful in monitoring health. It may
be particularly important to understand the gut derived volatilome both directly and indirectly due to
the important role the microbiome plays in human health. Tables 5 and 6 show the retention indices for
each compound calculated from the sample versus the literature values, in all cases where literature
values exist or samples matched closely. Table S14 shows the RI values for all chromatographic
peaks detected across all samples and compares those to the literature. In the vast majority of cases,
our experimental value is in-line with those in the literature. Figures S3–S14 in the Supplementary
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Materials shows the mass spectra for each of the compounds in Tables 5 and 6. Trimethylamine was
checked against the standards used for quantification. Future work will include verifying all of these
compounds with chemical standards.
Table 5. Details of 12 compounds identified from the headspace above stool samples from healthy
individuals that have not been previously reported in the literature [31].
CAS Compound Retention Time(min)
Retention Indices
Sample
Retention Indices
Literature
563-80-4 3-Methyl-2-butanone 4.56 972 970 [36]
556-24-1 3-Methylbutanoic acid methylester 5.49 1017 1024 [37]
97-87-0 Propanoic acid 2-methylbutylester 8.18 1152 1154 [37]
539-90-2 Butanoic acid 2-methylpropylester 8.45 1158 11,152 [37]
141-06-0 Pentanoic acid propyl ester 9.73 1215 1200–1233 [38]
1618-26-4 2,4-Dithiapentane 10.6 1260 1260 [39]
2313-61-3 2-heptanol 11.66 1308 1315.3 [40]
15356-70-4 5methyl-2-(1-methylethyl)-(1a,2b,5a)(Menthol) 16.9 1631 1630.4 [40]
55012-32-3 4-Isopropyl benzaldehyde(cuminaldehyde) 18.91 1783 1781.4 [40]
Bianchi et al. evaluated the retention indices for 250 compounds based on a polar column similar to that used to
carry out our work [38]. Babushok, Linstrom, and Zenkevich reported the retention indices for 505 compounds
frequently occurring in plant essential oils [40].
Table 6. Three compounds, previously unreported in the literature [31], identified from the headspace
of alkaline treated stool samples.
CAS Compound Retention Time (min) Retention IndicesSample
Retention Indices
Literature
75-50-3 Trimethylamine 1.95 - -
108-64-5 3-Methyl butanoicacid ethyl ester 6.48 1074 1068 [38]
926-64-7 Acetonitrile(dimethylamino) 10.02 1230 1243 [41]
4. Materials and Methods
4.1. Instrumentation and Separation Methodology
A Clarus 600 gas chromatograph (GC) and Clarus 600 T mass spectrometer (MS) (Perkin Elmer,
Buckinghamshire, UK) was used for all the experiments described.
The GC used a 30 m × 0.25 mm SOLGEL-WAX 0.25 µm column (Trajan scientific Europe Ltd.).
The GC method started at 40 ◦C with a 4-min hold, then ramped at a rate of 8 ◦C per minute to 240
◦C, with a final 4-min hold, and a total run time of 33 min. The MS was set to scan m/z 29–450 with
electron ionisation selected.
The automated thermal desorption (ATD) unit was a Turbo matrix 350 (Perkin Elmer,
Buckinghamshire, UK). TD tubes were filled with Tenax TA 26 mg and Sulficarb 68 mg absorbents
(Markes International Ltd., Llantrisant, UK). The valve was set to 215 ◦C with a tube temperature
of 315 ◦C. The transfer temperature was set to 300 ◦C with a trap rate of 99 ◦C/second; the trap low
and high was set to −20 ◦C and 320 ◦C, respectively. The dry purge time was 5 min and the desorb
time was 10 min with a 1.2 mL/min column flow rate. The outlet split was 2 mL/min and the desorb
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was 180 mL/min; the inlet split was 25 mL/min with a 50 mL/min dry purge. The heated purge
temperature was 50 ◦C.
4.2. Loading the Thermal Desorption (TD) Tubes
Thermal desorption (TD) tubes were loaded using an adapted single shot heated auto sampler
from an SRI GC instrument. This has a temperature controlled heating block. In the modified version,
2 needles pierce the headspace vial, one that allows the nitrogen purge gas (BOC UN1066 99.998%) to
enter the vial, and the other, which is securely attached to the TD tube with brass fittings (Swagelok).
The vials were 10 mL glass headspace vials with a screw top phenolic cap and PTFE/silicone septa
(Supelco, Bellefonte, PA, USA). The SRI GC instrument uses an EPC valve to control the purge gas flow,
which was set to 80 mL/min and flowed through the headspace vial containing the sample. The purge
gas is flowed through the vial and out through the TD tube for 2 min; the flow rate through the tube
was checked each time using a Perkin Elmer PE 1000 flow meter (Perkin Elmer, Buckinghamshire, UK).
1 µL standards dissolved in methanol were injected onto the TD tube using a 1 µL syringe
(SGE analytical science, Ringwood, Australia) (see standard solutions section for details on solutions
used) and loading rig (Markes International Ltd., Llantrisant, UK). Following the injection, nitrogen
gas (BOC UN1066 99.998%) was flowed through the tube at 80 mL/min for 2 min to remove excess
solvent prior to analysis. Flow was measured each time using a Perkin Elmer PE 1000 flow meter
(Perkin Elmer, Buckinghamshire, UK).
Once the tube was loaded, it was added immediately to the ATD unit carousel and analysed
within 30 min using the ATD-GC-MS.
4.3. Standard Solutions
Two solutions were used for this work. Table S27 shows solution 1, and 13C labelled compounds,
which were used as internal standards in the samples and for the calibration curves (see Section 2.4
calibration curves). Table S28 shows solution 2, made of non-labelled compounds used for
calibration curves. Both solutions were made up in methanol HPLC grade (Sigma Aldrich Company,
Gillingham, UK) and stored at 4 ◦C.
4.4. Calibration Curves
5 mL of solution 1 was sequentially diluted by factors of 10 and 100, using methanol. 0.5 µL of
the solutions 1 and 2, and the sequentially diluted solutions, were injected on to TD tubes following
the steps described in Section 4.2 of loading TD tubes. These were then analysed on the GC-MS, and
the peak areas were recorded and noted for each compound. Calibration curves were created for
each compound; none of the compounds in solution 1 or solution 2 yielded an r2 of less than 0.99.
Retention indices for all the standards were compared to that of the literature, and in all cases, the
values obtained from our data matched the literature values.
4.5. Sample Preparation
Stool samples were collected from 38 healthy volunteers, age range of 18–60 years, with full ethical
consent (research ethics committee reference 14/NE/0029); these were immediately refrigerated (4 ◦C)
on arrival and processed in a microbiological safety cabinet within 4 h. Samples were initially collected
in aluminium containers, L 20 cm ×W 11.5 cm × H 4 cm. Processing involved taking 6–8 aliquots
weighing 3 g from each sample and placing them into 10mL headspace vials (Supelco), which were
then frozen at −20 ◦C. The ethnic origin and the omnivore/ vegetarian status of the samples is shown
in Table 7.
For analysis, the sample vial was removed from the freezer and immediately the screw cap was
removed and a steel ball bearing (0.5 cm diameter, weighing approximately 0.5 g) was added and
the vial recapped. Next, 1 µL of solution 1 (see standard solutions section) was injected through the
septa using a 1 µL syringe (SGE analytical science). The vial was then inserted into the TD loading rig
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heating block at 30 ◦C for 10 min, manually shaken for ca. 1 min, and returned to the block. After a
further 10 min, the vial was shaken for a second time; then, it was returned to the block for a further
10 min, giving a total 30 min of heating time (see Section 4.2 loading TD tubes section for details).
Table 7. A breakdown of the participants by country of origin and omnivore/vegetarian status.
Number of Participants Ethnic Origin Omnivore Vegetarian
16 UK 8 8
11 South America (Brazil, Mexico) 10 1
3 Mainland Europe (Czech Republic, Latvia, and Spain) 1 2
5 Asia (China, Vietnam, Iran) 4 1
3 Africa (Maldives, Nigeria) 1 2
4.6. Trimethylamine Quantification in Ph13 Stool Samples
Trimethylamine solution standards were made separately. 25 mg of 13C trimethylamine
(99% Cambridge Isotope Laboratories Ltd., Tewksbury, MA, USA) was dissolved into 25 mL of
methanol to give a final concentration of 1 mg/mL (most concentrated), and this 1 mg/mL solution
was sequentially diluted to 0.1 mg/mL and 0.01 mg/mL. Trimethylamine, 400 mg (25 wt % in
water, Sigma Aldrich Company, Gillingham, UK) was dissolved in 100 mL methanol to give the
same 1 mg/mL concentration, which was again used as the most concentrated standard. This was
diluted 10 fold to give 0.1 mg/mL and 0.01 mg/mL. These solutions were used to create calibration
curves of the mass of compounds (x-axis) versus peak area recovered from the chromatogram (y-axis)
(see calibration curves Section 4.4).
The same sample processing took place as described in the sample preparation section above;
however, in the case when the ball bearing was added to the sample on removal from the freezer, 5 mL
of aqueous 0.1 M sodium hydroxide (Fisher Scientific, Loughborough, UK) was also pipetted into
the sample. The pH of the stool samples were checked post analysis with indicator paper. A total of
15 stool samples were run using this method.
4.7. Analysis
4.7.1. Qualitative Analysis
A signal threshold of 3 times the noise was set for all chromatograms. All peaks were searched
manually using the NIST library (NIST 08). Compounds with a match and reverse match above
800 were identified. If the match and/or reverse match was under 800, then the peak was listed as
unidentified. Terpene and siloxane compounds were difficult to assign structures to and thus were
listed under the chemical class name.
4.7.2. Mass Calculations Using 13C Labelled Compounds
Using solution 1, the following compounds were quantified: Dimethyl sulphide, acetone, butanoic
acid ethyl ester, 2-methylbutanoic acid ethyl ester, dimethyl disulphide, 1-octen-3-one, dimethyl
trisulphide, 1-octen-3-ol, ethanoic acid, butanoic acid, 3-methylbutanoic acid, pentanoic acid, indole,
and 3-methylindole. Peak areas of the quantified compounds were corrected using the recoveries of
the 13C labelled compounds (the calculations used for this are detailed in the Supplementary Materials
calculations for the quantification of compounds section).
4.7.3. Statistical Analysis
Basic descriptive statistics (mean and range numbers of chromatic peaks) were carried out on
the qualitative data. The differences between samples (e.g., UK origin versus South American origin)
have been discussed. Also discussed is the difference in chromatic peaks both qualitatively and
quantitatively for unmodified stool versus pH 13 stool.
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The 2 largest groups of participants with different geographical origins were from the UK and
South America, thus these groups were selected for comparison. Omnivore and vegetarian groups from
the entire cohort of participants were also compared. Descriptive statistics, such as the mean, standard
deviation, and the ranges, were carried out in the first instance. To compare sample groups, a Mann
Whitley U test was carried out before a discriminant analysis using stepwise statistics (Wilks’ Lambda).
Leave-one-out cross validation was used to calculate an ROC curve. All statistical analysis was carried
out using IBM SPSS statistics version 24.
5. Conclusions
We have presented a method for the analysis of stool samples whereby the addition of 13C
compounds has allowed us to quantify a range of VOCs in stool: Dimethyl sulphide (26–25,626 ng/g),
acetone (442–3006 ng/g), ethyl butanoate (39–2468 ng/g), ethyl 2-methylbutanoate (0.3–180 ng/g),
dimethyl disulphide (35–1303 ng/g), 1-octen-3-one (12 ng/g), dimethyl trisulphide (10–410 ng/g),
1-octen-3-ol (0.4–58 ng/g), ethanoic acid (672–12,963 ng/g), butanoic acid (2493–11,553 ng/g),
3-methylbutanoic acid (64–8262 ng/g), pentanoic acid (88–21,886 ng/g), indole (290–5477 ng/g),
and 3-methyl indole (37–3483 ng/g). Moreover, by altering the pH of the stool to pH 13, in conjunction
with the addition of 13C trimethylamine, we have also been able to detect and quantify trimethylamine
for the first time (range 40–5312 ng/g). We were able to gather stool samples from participants of
different countries of origin, which allowed us to compare the quantities of compounds from samples
of UK origin with those of South American origin. Using a Mann Whitney U test, five compounds, ethyl
butanoate, 1-octen-3-ol, ethanoic acid, butanoic acid, pentanoic acid, and indole, were calculated to be
significantly different between South American and UK samples. Wilks’ Lambda analysis showed that
butanoic acid and ethyl butanoate could be used to differentiate the two groups. This has important
implications for future studies looking to develop diagnostic tests based on VCs, especially where these
diagnostics are not based on distinct markers of disease, but on changes in a number of VCs that are
commonly observed in healthy individuals. However, no significant differences between omnivores
and vegetarians were observed in this study, in agreement with previous studies. Additionally, we
have been able to tentatively identify 15 compounds that have not previously been reported from stool
samples. This data adds to the understanding of the human volatilome.
Supplementary Materials: The following are available online at http://www.mdpi.com/2218-1989/8/4/75/s1.
Tables S1–S12 containing all found chromatographic peaks sorted by chemical family and retention time, also the
peak area for each peak is shown. Table S13 shows the experimental retention indices for all the compounds and
compares them to the literature values. Table S14 showing the calculated masses of 13 compounds found in stool.
Tables S15 to S25 show all of the chromatographic peaks found in the stool with added sodium hydroxide, sorted
by chemical family and retention time. Table S26 shows the quantification of compounds from the headspace.
Tables S27 and S28 show the chemicals and concentrations along with supplier of the compounds used in
the calibration standards. Figures S1 and S2 detail the difference in the unaltered versus the pH 13 stool and
demonstrate the appearance of trimethylamine. Figures S3 to S14 show the mass spectra for the compounds not
previously identified in stool samples. Also detailed are the calculations for the quantification of compounds.
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